The Zhitong Finance App learned that according to the latest data from the Hong Kong Stock Exchange, on August 27, Li Ankang reduced his holdings of Tengsheng Pharmaceutical-B (02137) by 1,500 shares, at a price of HK$0.955 per share, for a total amount of HK$0.14 million. The latest number of shares held after the reduction was 8.383,500 shares, and the latest shareholding ratio was 1.14%.

Additional information: 1,500 shares were sold to cover the tax payment for the RSUS vested on August 26, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.